
Bio-Rad Laboratories, Inc.
BIO-B
Updated: 24/09/2026, 11:39:11
Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.
No summaries found.
- Share price
- $374.77
- Market cap
- $10.25B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Norman D. Schwartz
- Employees
- 7,450
- IPO date
- 21/09/1999
- Beta
- 1.112
- Last dividend
- $0.00
- Day range
- $374.77 – $385.78
- 52-week range
- $244.54 – $387.10
- 1-day performance
- 2.65%
- 1-year performance
- 53.26%
- Current drawdown (1Y)
- -3.19%
- CIK
- 0000012208
- CUSIP
- 090572108
- ISIN
- US0905721082
- Created
- 07/12/2025, 03:00:01
- Last update
- 24/09/2026, 11:39:11
Track Bio-Rad Laboratories, Inc. with an AI analyst
See which prediction-market events move BIO-B, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.